TY - JOUR T1 - N-Acetylcysteine and disease progression in COPD JF - Thorax JO - Thorax SP - 622 LP - 622 VL - 60 IS - 8 AU - K Satkunam Y1 - 2005/08/01 UR - http://thorax.bmj.com/content/60/8/622.abstract N2 - ▴ Decramer M, Rutten-van Mölken M, Dekhuijzen PR, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (Bronchitis Randomized on NAC Cost-Utility Study, BRONCUS): a randomized placebo-controlled trial. Lancet2005;365:1552–60OpenUrlCrossRefPubMedWeb of Science It is known that oxidative stress plays an important role in the pathogenesis of chronic obstructive pulmonary disease (COPD). In this study the anti-oxidant N-acetylcysteine (NAC) was used to assess whether this drug could … ER -